News

CloudMD Reports Robust Results in Restated, Q3 2023 Financial Results

Reports filing of Restated Q3 2023 Financial Statements and Restated 2022 Audited Consolidated Financial StatementsThird Quarter HighlightsNet Loss of $5.4…

4 months ago

FendX Signs Collaborative Research Agreement with McMaster for Development of Catheter Coating Using Its Nanotechnology

Oakville, Ontario--(Newsfile Corp. - December 13, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or…

4 months ago

Juva Life Reports Strong Growth in Q3 2023 Financial Results

REDWOOD CITY, CA / ACCESSWIRE / December 13, 2023 / Juva Life Inc. (CSE:JUVA)(OTCQB:JUVAF)(FRANKFURT:4VV) ("Juva Life" or the "Company"), Juva…

4 months ago

TridentCare to Grow and Enhance Its Laboratory Services Business With the Addition of a Seasoned Diagnostic Operator

SPARKS, MD / ACCESSWIRE / December 12, 2023 / TridentCare is pleased to announce the addition of Chris Tomlinson, MBA,…

4 months ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million

HACKENSACK, NJ / ACCESSWIRE / December 12, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services…

4 months ago

Preventogen is a New Tool in the Fight Against Antibiotic-Resistant Infections Caused by Superbugs, a Leading Cause of Death Worldwide

Preventogen's FDA-Cleared Microbicidal Liquid Polymer Ensures the Eradication of These Dangerous Pathogens on Contact While Forming a More Effective and…

4 months ago

Delivra Health Brands Announces Closing of Non-Brokered Private Placement of Units

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2023) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or…

4 months ago

Calyxo Closes on $50 Million Equity Financing to Support Broad Launch of CVAC Kidney Stone Treatment

Investment Round will Fund Expansion of Commercial Team and Further Product DevelopmentPLEASANTON, Calif.--(BUSINESS WIRE)--#CVAC--Calyxo, Inc., a medical device company developing…

4 months ago

The Osmolality Lab Appoints New CEO as Expansion Continues

Nicholas D. Gillitt, PhD, will assume the role of Chief Executive Officer of The Osmolality Lab, a global leader in…

4 months ago

MATTER opens applications for accelerator focused on reducing maternal mortality in the U.S.

Health Care Service Corporation, Laerdal Million Lives Fund, BayCare, Parkview Health, University of Chicago Medicine, Organon and Stryker to support…

4 months ago